首页 > 最新文献

Immuno-oncology technology最新文献

英文 中文
49P Highly potent novel armoured IL13Ra2 CAR T cell targeting glioblastoma
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100860
M. Mangolini , S. Srivastava , E. Souster , Y. Yang , R. Karatill , L. Schultz , B. Ma , D. Pombal , A. Ramon , M. Greenig , P. Sormanni , S. Cordoba , S. Onuoha
{"title":"49P Highly potent novel armoured IL13Ra2 CAR T cell targeting glioblastoma","authors":"M. Mangolini , S. Srivastava , E. Souster , Y. Yang , R. Karatill , L. Schultz , B. Ma , D. Pombal , A. Ramon , M. Greenig , P. Sormanni , S. Cordoba , S. Onuoha","doi":"10.1016/j.iotech.2024.100860","DOIUrl":"10.1016/j.iotech.2024.100860","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100860"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143129092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5MO Novel radiologic phenotypes of chaotic tumor angiogenesis associated with poor ICI outcomes in NSCLC
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100889
V. Velcheti , R. Chitalia , C. Leibowitz , K. Zhang , A. Madabhushi , N. Braman
{"title":"5MO Novel radiologic phenotypes of chaotic tumor angiogenesis associated with poor ICI outcomes in NSCLC","authors":"V. Velcheti , R. Chitalia , C. Leibowitz , K. Zhang , A. Madabhushi , N. Braman","doi":"10.1016/j.iotech.2024.100889","DOIUrl":"10.1016/j.iotech.2024.100889","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100889"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143132190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
90P Meta-analysis of hypophysitis incidence in melanoma patients treated with immune checkpoint inhibitors
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100833
V. Urbonas , P. Bernotas , M. Grubliauskaite , D. Dabkeviciene
{"title":"90P Meta-analysis of hypophysitis incidence in melanoma patients treated with immune checkpoint inhibitors","authors":"V. Urbonas , P. Bernotas , M. Grubliauskaite , D. Dabkeviciene","doi":"10.1016/j.iotech.2024.100833","DOIUrl":"10.1016/j.iotech.2024.100833","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100833"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
101P Comparison on the effectiveness of multiple single and double immunotherapy treatments on advanced angiosarcoma patients: Meta analysis & systematic review
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100844
E. Marson
{"title":"101P Comparison on the effectiveness of multiple single and double immunotherapy treatments on advanced angiosarcoma patients: Meta analysis & systematic review","authors":"E. Marson","doi":"10.1016/j.iotech.2024.100844","DOIUrl":"10.1016/j.iotech.2024.100844","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100844"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41P Total tumor burden and radiomics to evaluate response in dose escalation studies: Roginolisib (IOA-244), a highly selective PI3Kδ inhibitor in metastatic uveal melanoma patients
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.101001
A.M. Di Giacomo , A. Corsi , N. Sindhwani , A. Rasooli , M.H. Nawaz , F. Belmans , C.C. Meca , M. Maio , T.R.J. Evans , A. Santoro , M. Lahn , W. Vos
{"title":"41P Total tumor burden and radiomics to evaluate response in dose escalation studies: Roginolisib (IOA-244), a highly selective PI3Kδ inhibitor in metastatic uveal melanoma patients","authors":"A.M. Di Giacomo , A. Corsi , N. Sindhwani , A. Rasooli , M.H. Nawaz , F. Belmans , C.C. Meca , M. Maio , T.R.J. Evans , A. Santoro , M. Lahn , W. Vos","doi":"10.1016/j.iotech.2024.101001","DOIUrl":"10.1016/j.iotech.2024.101001","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 101001"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
24P Blood DNA methylation profiles in NSCLC patients treated with immune checkpoint inhibitors
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100906
M. Kleinberger , E. Tomasich , J.M. Berger , V. Sunder-Plassmann , L. Gottmann , I. Solano Henao , M. Korpan , J.H. Fürst , C. Englisch , C. Ay , H. Haslacher , J. Furtner , M. Preusser , A.S. Berghoff , G. Heller
{"title":"24P Blood DNA methylation profiles in NSCLC patients treated with immune checkpoint inhibitors","authors":"M. Kleinberger , E. Tomasich , J.M. Berger , V. Sunder-Plassmann , L. Gottmann , I. Solano Henao , M. Korpan , J.H. Fürst , C. Englisch , C. Ay , H. Haslacher , J. Furtner , M. Preusser , A.S. Berghoff , G. Heller","doi":"10.1016/j.iotech.2024.100906","DOIUrl":"10.1016/j.iotech.2024.100906","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100906"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6MO Single-cell analysis of peripheral blood mononuclear cells reveals therapy outcomes are associated with pre-existing immunity in patients treated with oncolytic adenovirus armed with TNFα and IL2
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100890
T. Kudling , D. Bychkov , J. Clubb , S.A. Pakola , V. Arias , E. Jirovec , M. van der Heijden , N. Ojala , D.C.A. Quixabeira , L. Haybout , K. Jalkanen , T.V. Alanko , R. Havunen , S. Sorsa , C. Kistler , A. Kanerva , O.J. Hemminki , J. Santos , V. Cervera-Carrascon , A. Hemminki
{"title":"6MO Single-cell analysis of peripheral blood mononuclear cells reveals therapy outcomes are associated with pre-existing immunity in patients treated with oncolytic adenovirus armed with TNFα and IL2","authors":"T. Kudling , D. Bychkov , J. Clubb , S.A. Pakola , V. Arias , E. Jirovec , M. van der Heijden , N. Ojala , D.C.A. Quixabeira , L. Haybout , K. Jalkanen , T.V. Alanko , R. Havunen , S. Sorsa , C. Kistler , A. Kanerva , O.J. Hemminki , J. Santos , V. Cervera-Carrascon , A. Hemminki","doi":"10.1016/j.iotech.2024.100890","DOIUrl":"10.1016/j.iotech.2024.100890","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100890"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
95P Quality of life (QoL) and care pathway in patients with durable response to immune checkpoint inhibitors (ICI-DR) for advanced or metastatic non-small cell lung cancer (NSCLC) or melanoma: QUALICI study
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100838
N. Girard , J. Bonastre , G. Spurrier-Bernard , H. Lemasson , M. Chartier , V. Moreau-Mallet , S. Micheliza , N. Texier , S. Hervy , M. Coin-Bavarot , C. Robert
{"title":"95P Quality of life (QoL) and care pathway in patients with durable response to immune checkpoint inhibitors (ICI-DR) for advanced or metastatic non-small cell lung cancer (NSCLC) or melanoma: QUALICI study","authors":"N. Girard , J. Bonastre , G. Spurrier-Bernard , H. Lemasson , M. Chartier , V. Moreau-Mallet , S. Micheliza , N. Texier , S. Hervy , M. Coin-Bavarot , C. Robert","doi":"10.1016/j.iotech.2024.100838","DOIUrl":"10.1016/j.iotech.2024.100838","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100838"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
92P An investigation on the differences between the pre-treatment nutritional and immunological status of nasopharyngeal carcinoma patients and the healthy population
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100835
Q. He , M. Yang , D. Wang , Y. Huang
{"title":"92P An investigation on the differences between the pre-treatment nutritional and immunological status of nasopharyngeal carcinoma patients and the healthy population","authors":"Q. He , M. Yang , D. Wang , Y. Huang","doi":"10.1016/j.iotech.2024.100835","DOIUrl":"10.1016/j.iotech.2024.100835","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100835"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
65O CheckMate 73L: Phase III study comparing nivolumab (N) + concurrent chemoradiotherapy (CCRT) followed by N ± ipilimumab (I) v CCRT followed by durvalumab (D) for previously untreated, locally advanced stage (stg) III NSCLC
Immuno-oncology technology
Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100808
S. Peters , D.S.W. Tan , D.E. Gerber , J. Urbanic , S.S. Ramalingam , J. Yu , L. Xing , A. Rittmeyer , T-E. Ciuleanu , J. Menezes , H.R. Kim , C.I. Rojas , K. Syrigos , H. Hayashi , A. Haridass , S. Bordenave , R. Nathani , G. Pudussery , L. Yang , D. De Ruysscher
{"title":"65O CheckMate 73L: Phase III study comparing nivolumab (N) + concurrent chemoradiotherapy (CCRT) followed by N ± ipilimumab (I) v CCRT followed by durvalumab (D) for previously untreated, locally advanced stage (stg) III NSCLC","authors":"S. Peters , D.S.W. Tan , D.E. Gerber , J. Urbanic , S.S. Ramalingam , J. Yu , L. Xing , A. Rittmeyer , T-E. Ciuleanu , J. Menezes , H.R. Kim , C.I. Rojas , K. Syrigos , H. Hayashi , A. Haridass , S. Bordenave , R. Nathani , G. Pudussery , L. Yang , D. De Ruysscher","doi":"10.1016/j.iotech.2024.100808","DOIUrl":"10.1016/j.iotech.2024.100808","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100808"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Immuno-oncology technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1